Phase I trial of oral irinotecan and temozolomide for children with relapsed high-risk neuroblastoma : A New Approach to Neuroblastoma Therapy Consortium study

1 Citations

Journal

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1570854175908262784
  • NII Article ID
    10025289336
  • Data Source
    • CiNii Articles

Report a problem

Back to top